# Post-Ablation Pericarditis Reduction Study

Study · id `cardio:ct-nct04906720` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04906720](<https://clinicaltrials.gov/study/NCT04906720>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04906720

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.

## Technical summary

Registry record NCT04906720. Randomized; no masking; primary purpose prevention. Start 2021-05-20 (actual); primary completion 2022-01-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 248 participants (enrolled count; ClinicalTrials.gov record NCT04906720, source copy `cardio:ctgov-nct04906720-2022-11-08`, retrieved 2026-10-26)
- Started: 2021-05-20 (actual) (ClinicalTrials.gov record NCT04906720, source copy `cardio:ctgov-nct04906720-2022-11-08`, retrieved 2026-10-26)
- Primary completion: 2022-01-30 (actual) (ClinicalTrials.gov record NCT04906720, source copy `cardio:ctgov-nct04906720-2022-11-08`, retrieved 2026-10-26)
- Completion: 2022-10-01 (actual) (ClinicalTrials.gov record NCT04906720, source copy `cardio:ctgov-nct04906720-2022-11-08`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04906720, source copy `cardio:ctgov-nct04906720-2022-11-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04906720-2022-11-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Post-Ablation Pericarditis Reduction Study
- Acronym: PAPERS
- Condition: Atrial Fibrillation
- Condition: Catheter Ablation
- Condition: Pericarditis
- Intervention (Drug): Colchicine
- Lead sponsor: St. Vincent Cardiovascular Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: St. Vincent Cardiovascular Research Institute (`cardio:org-st-vincent-cardiovascular-research-institute`)

## Provenance

Content hash: 8ea6a16953804e7aeb6c0f742fa2ae45b362bfb24701e845a0ed39ebda089cb0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
